IMPACT Therapeutics has received the China National Medical Products Administration (NMPA) marketing authorisation for ...

A new pathway to fast track patients from the Preston area with suspected ovarian cancer is being implemented at the Royal ...

IMPACT Therapeutics ('IMPACT'), a biopharmaceutical company focusing on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, is pleased to announce that ...

Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Overall, surgical de-escalation in gynecologic oncology increased from 2004 to 2020, with a growing shift toward minimally ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...

The new NCCN Guidelines for Patients®: Genetic Testing for Hereditary Breast, Ovarian, Pancreatic, and Prostate Cancer is ...

Stay positive!” Those are the two words a lifelong friend had texted me when I shared that something suspicious had appeared ...

Cancer mortality rates have decreased by 34% overall, but incidence rates for women of all ages continue to rise, according ...

NHS Shared Business Services has issued a tender worth £150m, split into six lots, covering the use of artificial ...